How WuXi AppTec's Integrated CRDMO Model Supports Biotechnology Companies from Discovery to IND

Learn how WuXi AppTec's integrated CRDMO model connects biology, DMPK, toxicology, bioanalysis and CMC to accelerate IND readiness.

2026/05/19

WuXi AppTec Expands Global Manufacturing Capacity as Customer Demand Accelerates

WuXi AppTec, a global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), is adding significant new drug substance and drug product manufacturing capacity over the next two years across the United States, Europe, and Asia, to meet growing demand from its global customer base.

2026/05/19

Confidence Behind Clean Audit Records: WuXi AppTec Bioanalytical Services as the Guardian of New Drug Bioanalysis

“Every drug can be made, and every disease can be treated.” Since 2000, from a single laboratory to a global network spanning Asia, Europe, and North America; from early chemical synthesis services to an integrated platform that connects Research (R), Development (D), and Manufacturing (M); from its very first customer to numerous partners across more than 30 countries, WuXi AppTec has never stopped moving forward to realize its enduring vision. Find out how WuXi AppTec’s integrated CRDMO platform enables innovation, accelerates R&D, and advances more new therapies to patients around the world.

2026/04/09

WuXi AppTec Advances Healthcare Innovation Worldwide with A Consistent Mission

Since its founding in 2000, WuXi AppTec’s mission has remained constant: to help global customers and partners discover, develop, and manufacture pharmaceuticals and healthcare products to benefit patients in need.

2026/04/08

Turning Possibility into Probability: How WuXi AppTec Helps New Science Become Real Medicines

In drug discovery, innovative ideas emerge every day: scientists uncover novel mechanisms for disease treatment, previously “undruggable targets” begin to come within reach, and new modalities show potential in addressing complex diseases. However, there is often still a gulf between promising science and real-life therapies.

1 2 3

Our Role

How WuXi AppTec's Integrated CRDMO Model Supports Biotechnology Companies from Discovery to IND

WuXi AppTec Expands Global Manufacturing Capacity as Customer Demand Accelerates

Confidence Behind Clean Audit Records: WuXi AppTec Bioanalytical Services as the Guardian of New Drug Bioanalysis

WuXi AppTec Advances Healthcare Innovation Worldwide with A Consistent Mission

Turning Possibility into Probability: How WuXi AppTec Helps New Science Become Real Medicines